Kyorin Pharmaceuticals acquires jTAS Co., a leader in portable PCR analysis

jTAS has developed a portable (4 kg), battery-driven PCR device which permits the analysis of 0.2 fM or less of DNA within 5 – 8 minutes (30 – 40 reaction cycles). The equipment has been used in the analysis of respiratory and urinary tract infections as well as in the detection of pathogenic microorganisms.

Kyorin news release, June 23, 2017

Kyorin Pharmaceuticals acquires jTAS Co., a leader in portable PCR analysis
Scroll to top